Leerink Partners Maintains Outperform on Pharvaris, Raises Price Target to $65

Benzinga · 3d ago
Leerink Partners analyst Joseph Schwartz maintains Pharvaris (NASDAQ:PHVS) with a Outperform and raises the price target from $50 to $65.